A Dose Escalation Study of a Combination Antihypertensive Drug in the Treatment of Various Groups of Patients Who do Not Respond to Single Drug Treatment of Their High Blood Pressure
Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Daiichi Sankyo
With
Integrium
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
\>= to 18 years of age
Hypertension uncontrolled on current monotherapy
Females:
negative serum pregnancy test at screening
post menopausal or have had a hysterectomy or tubal ligation or practicing approved methods of birth control
You may not be if
Pregnant females
Uncontrolled hypertension with multiple drugs, except for hydrochlorothiazide/triamterene
Diabetes requiring insulin
Serious disorders that may limit the ability to evaluate the efficacy or safety of treatment
History of myocardial infarction, bypass graft, angioplasty or heart failure within the past 6 months
History of Class III or IV congestive heart failure
History of stroke or transient ischemic attack within the last 1 year
Clareo Health | A Dose Escalation Study of a Combination Antihypertensive Drug in the Treatment of Various Groups of Patients Who do Not Respond to Single Drug Treatment of Their High Blood Pressure
